People In The News

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – James Flatt will join Synthetic Genomics as chief technology officer as of next week. Flatt formerly was executive VP of R&D and operations and acting president at Mascoma, where he led a team of 70 scientists and engineers studying yeast strain development and metabolic engineering. He also previously was senior VP of research for Martek Biosciences and VP of R&D at Omegatech.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.